Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences

Hepatology

Volumn 48, Issue 5, 2008, Pages 1570-1576

  Gincul, Rodica ^a   Lesca, Gaetan ^b   Gelas Dore, Bénédicte ^c   Rollin, Nathalie ^c   Barthelet, Martine ^d   Dupuis Girod, Sophie ^b   Pilleul, Franck ^c   Giraud, Sophie ^c   Plauchu, Henri ^b   Saurin, Jean Christophe ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HÔTEL DIEU   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE TYPE 1; ENDOGLIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; HEART DISEASE; HEART INDEX; HEPATIC ARTERY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER DISEASE; LIVER FOCAL NODULAR HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENDU OSLER WEBER DISEASE; ECHOGRAPHY; GENETICS; HEART MUSCLE; HYPERPLASIA; LIVER; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; HEART DISEASES; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; MYOCARDIUM; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 56149120667     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22514     Document Type: Article

References (24)

1. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91: 66-67.
2. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169:994-1000.
3. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-297.
4. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia [scee commentsc]. N Engl J Med 1995;333:918-924.
5. Abdalla SA, Geisthoff UW, Bonneau D, Plauchu H, McDonald J, Kennedy S, et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003;40:494-502.
6. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: Clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology 1993;105:482-487.
7. Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabba C, Angelelli G. Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 2004;29:211-220.
8. Buscarini E, Plauchu H, Garcia Tsao G, White RI Jr, Sabba C, Miller F, et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 2006;26:1040-1046.
9. Buscarini E, Danesino C, Olivieri C, Lupinacci G, Zambelli A. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis 2005;37:635-645.
10. Caselitz M, Bahr MJ, Bleck JS, Chavan A, Manns MP, Wagner S, et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). HEPATOLOGY 2003;37:1139-1146.
11. Ravard G, Soyer P, Boudiaf M, Terem C, Abitbol M, Yeh JF, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: Helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 2004;28:488-495.
12. Buscarini E, Danesino C, Plauchu H, de Fazio C, Olivieri C, Brambilla G, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004;30: 1089-1097.
13. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986;110:331-335.
14. Lesca G, Burnichon N, Raux G, Tosi M, Pinson S, Marion MJ, et al. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Hum Mutat 2006;27:598.
15. Lesca G, Plauchu H, Coulet F, Lefebvre S, Plessis G, Odent S, et al. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat 2004;23:289-299.
16. Buscarini E, Buscarini L, Civardi G, Arruzzoli S, Bossalini G, Piantanida M. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Imaging findings. AJR Am J Roentgenol 1994;163: 1105-1110.
17. Buscarini E, Buscarini L, Danesino C, Piantanida M, Civardi G, Quaretti P, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997; 26:111-118.
18. Naganuma H, Ishida H, Niizawa M, Igarashi K, Shioya T, Masamune O. Hepatic involvement in Osler-Weber-Rendu disease: Findings on pulsed and color Doppler sonography. AJR Am J Roentgenol 1995;165:1421-1425.
19. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-936.
20. Boillot O, Bianco F, Viale JP, Mion F, Mechet I, Gille D, et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 1999; 116:187-192.
21. Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, et al. Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003;40:585-590.
22. Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006;43:371-377.
23. Kuehl HK, Caselitz M, Hasenkamp S, Wagner S, El-Harith el HA, Manns MP, et al. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: Identification of five novel ALK1 and one novel ENG mutations. Hum Mutat 2005;25:320.
24. Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: Etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 2001;16:1319-1328.